Zydus Lifesci
₹1,132
- Market Cap
- ₹1,12,195Cr.
- P/E Ratio
- 23.1
- P/B Ratio
- 4.21
- EPS (TTM)
- ₹49.00
- Div Yield
- 0.09%
- ROCE
- 21.1%
- ROE
- 21.2%
52W Low: ₹83652W High: ₹1,232
Themes:💊 Pharma & CDMO
Appears in 1 screen
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 16.0% a year over three years.
- Debt is 0.46× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Zydus_Lifesci — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 23.1P/E: 23.1 | P/B: 4.21Growth
GrowingSales CAGR — 3Y: 16% · 1Y: 21%Profitability
High MarginROCE: 21.1% | ROE: 21.2%Key Metrics
Valuation
PEG Ratio 0.72
Price / Sales 3.92x
Book Value ₹269
Margins & returns
Operating Margin 29%
Net Margin 16.1%
Return on Assets 9.1%